Table 1.
Group | n | Body weight (g) | Liver weight (g) |
Thioacetamide series | |||
Stage 0 | 9 | 341 (15) | 14.8 (0.9) |
Stage 1 | 4 | 270 (9.0) | 11.1 (0.6) |
Stage 2 | 4 | 410 (15)* | 15.0 (1.6) |
Stage 3 | 7 | 423 (15)* | 19.1 (1.5)† |
Stage 4 | 9 | 415 (15)* | 19.7 (1.6)† |
Carbon tetrachloride series | |||
Stage 1 | 6 | 433 (12) | 11 (0.5) |
Stage 4 | 10 | 413 (11) | 13 (1.0) |
Common bile duct ligation series | |||
Baseline | 8 | 283 (7.0) | — |
Cholestasis | |||
11 days | 9 | 295 (7.0) | — |
26 days | 9 | 344 (10)‡ | — |
46 days | 7 | 376 (24)§ | 20.0 (2.1) |
Age matched controls | 4 | 461 (12) | 14.1 (0.9) |
Values are means (SEM).
*p<0.05 versus stages 0 and 1; †p<0.05 versus stage 1; ‡ p<0.05 versus baseline; § p<0.05 versus baseline and age matched controls.